This timely review examines the use of single and mutiple agents to decrease saphenous graft failure after CABG. These are difficult and expensive studies to perform, requiring repeat imaging after surgery, a procedure patients are often reluctant to undergo.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Antithrombotic Treatment After Coronary Artery Bypass Graft Surgery: Systematic Review and Network Meta-Analysis
October 11, 2019
EXCEL trial of PCI vs CABG Author withdraws his authorship from the NEJM paper citing a dangerous corruption of the results against the superior results of CABG
October 10, 2019
David Taggart, MD, PhD (University of Oxford, England), the chairman of the EXCEL surgical committee during the design and recruitment phase of the trial, believes the investigators downplayed the increased risk of all-cause mortality with PCI and oversold the reduced risk of the study’s primary composite endpoint of death, stroke, and MI, particular
October 8, 2019
This video describes a patient with a symptomatic paraganglioma who underwent resection with coronary sinus reconstruction.
Skeletonisation Contributing to a Reduction of Sternal Wound Complications: a Retrospective Study in OPCAB Patients
September 18, 2019
This is a retrospective study in OPCAB patients comparing patients who received skeletonized versus nonskeletonized SIMA and BIMA grafts. They reported patients with any sternal wound complication including redness or minor drainage that healed naturally.
September 16, 2019
This video illustrates two cases (right and left) of intramural coronary arteries and their surgical management using unroofing.
CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial
September 14, 2019
This study reports ten year outcomes of the STICH trial. Comparing CABG to medical therapy groups, the authors note that CABG reduced all cause, cardiovascular, and heart failure hospitalizations. This included time-to-first and recurrent events. This was due to fewer total cardiovascular hospitalizations, the majority due to heart failure.
September 3, 2019
In this interview, David Taggart, ART Trial Principal Investigator, critically evaluates the pros and cons of the trial and its key takeaways.
September 3, 2019
Remote ischemic preconditioning did not influence 12-month survival or readmission rates in a randomized trial involving more than 5,400 patients undergoing percutaneous coronary intervention after ST-segment elevation MI.
September 2, 2019
The authors reviewed the New York State database. Patients with single arterial grafts were compared to those with multiple arterial grafts. Propensity matching was performed based on 38 baseline characteristics. Twenty percent had multiple arterial grafting.
September 1, 2019
Interesting viewpoint of a cardiologist on low-SYNTAX subjects.